David Turkaly
Stock Analyst at JMP Securities
(2.25)
# 2,607
Out of 4,711 analysts
137
Total ratings
40.77%
Success rate
-3.39%
Average return
Main Sectors:
Stocks Rated by David Turkaly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STE STERIS | Reiterates: Market Outperform | $265 | $207.49 | +27.72% | 16 | Nov 18, 2024 | |
| NVRO Nevro | Reiterates: Market Perform | n/a | $3.79 | - | 14 | Nov 12, 2024 | |
| LNTH Lantheus Holdings | Maintains: Market Outperform | $125 → $112 | $89.29 | +25.44% | 7 | Nov 7, 2024 | |
| ENOV Enovis | Initiates: Market Outperform | $62 | $43.12 | +43.78% | 1 | Oct 3, 2024 | |
| APYX Apyx Medical | Reiterates: Market Perform | n/a | $1.57 | - | 5 | Sep 16, 2024 | |
| KIDS OrthoPediatrics | Reiterates: Market Outperform | $50 | $22.38 | +123.41% | 9 | Sep 13, 2024 | |
| STIM Neuronetics | Maintains: Market Outperform | $7 → $3 | $1.39 | +115.83% | 7 | Aug 14, 2024 | |
| HAE Haemonetics | Reiterates: Market Outperform | $125 | $75.44 | +65.69% | 10 | Aug 13, 2024 | |
| TELA TELA Bio | Maintains: Market Outperform | $15 → $12 | $2.85 | +321.05% | 5 | Aug 13, 2024 | |
| AXGN Axogen | Maintains: Market Outperform | $17 → $20 | $15.64 | +27.88% | 6 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $40 → $35 | $21.80 | +60.55% | 13 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $23 → $20 | $10.03 | +99.40% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $32 | $13.25 | +141.51% | 6 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $17.43 | - | 1 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $285 | $178.16 | +59.97% | 14 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $160 → $140 | $107.12 | +30.69% | 13 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $82.63 | - | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $4 | $1.83 | +118.58% | 4 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $8.67 | -42.33% | 1 | Oct 6, 2017 |
STERIS
Nov 18, 2024
Reiterates: Market Outperform
Price Target: $265
Current: $207.49
Upside: +27.72%
Nevro
Nov 12, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $3.79
Upside: -
Lantheus Holdings
Nov 7, 2024
Maintains: Market Outperform
Price Target: $125 → $112
Current: $89.29
Upside: +25.44%
Enovis
Oct 3, 2024
Initiates: Market Outperform
Price Target: $62
Current: $43.12
Upside: +43.78%
Apyx Medical
Sep 16, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $1.57
Upside: -
OrthoPediatrics
Sep 13, 2024
Reiterates: Market Outperform
Price Target: $50
Current: $22.38
Upside: +123.41%
Neuronetics
Aug 14, 2024
Maintains: Market Outperform
Price Target: $7 → $3
Current: $1.39
Upside: +115.83%
Haemonetics
Aug 13, 2024
Reiterates: Market Outperform
Price Target: $125
Current: $75.44
Upside: +65.69%
TELA Bio
Aug 13, 2024
Maintains: Market Outperform
Price Target: $15 → $12
Current: $2.85
Upside: +321.05%
Axogen
Aug 9, 2024
Maintains: Market Outperform
Price Target: $17 → $20
Current: $15.64
Upside: +27.88%
Jul 30, 2024
Maintains: Market Outperform
Price Target: $40 → $35
Current: $21.80
Upside: +60.55%
May 9, 2024
Maintains: Market Outperform
Price Target: $23 → $20
Current: $10.03
Upside: +99.40%
May 7, 2024
Reiterates: Market Outperform
Price Target: $32
Current: $13.25
Upside: +141.51%
Apr 22, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $17.43
Upside: -
Feb 23, 2024
Reiterates: Market Outperform
Price Target: $285
Current: $178.16
Upside: +59.97%
Nov 13, 2023
Maintains: Market Outperform
Price Target: $160 → $140
Current: $107.12
Upside: +30.69%
May 24, 2023
Reiterates: Market Perform
Price Target: n/a
Current: $82.63
Upside: -
Apr 13, 2023
Maintains: Outperform
Price Target: $7 → $4
Current: $1.83
Upside: +118.58%
Oct 6, 2017
Initiates: Outperform
Price Target: $5
Current: $8.67
Upside: -42.33%